Improving Stem Cell Treatment Success
Researchers will manipulate the expression of immune markers on stem cells to develop safer and more effective therapies for horses with musculoskeletal injuries.
Researchers will manipulate the expression of immune markers on stem cells to develop safer and more effective therapies for horses with musculoskeletal injuries.
Researchers will investigate the mechanisms leading to development and transmission of antimicrobial resistance in Rhodococcus equi, a bacterial agent that causes severe pneumonia in foals.
Researchers will investigate how diet influences a horse's gut bacteria (microbiome) and metabolism (metabolome) and impacts insulin, key information to understanding how to feed horses at risk for laminitis.
Researchers will investigate if vaccinating mares will protect their newborn foals against pneumonia caused by the bacterium Rhodococcus equi.
Researchers will determine the optimal intravenous and intra-articular dosing protocol for amikacin, an antibiotic used to treat bacterial infections in foals.
Researchers will investigate a new laboratory test to improve diagnosis of equine metabolic syndrome, a metabolic and hormonal disorder in horses.
Researchers will use molecular methods to identify which species of equine parasitic worms come back first after deworming.